ENTELLUS MEDICAL INC (ENTL) financial statements (2020 and earlier)

Company profile

Business Address 3600 HOLLY LANE NORTH
PLYMOUTH, MN 55447
State of Incorp. DE
Fiscal Year End December 31
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

9/30/2017
Q3
6/30/2017
Q2
3/31/2017
Q1
12/31/2016
Q4
9/30/2016
Q3
6/30/2016
Q2
3/31/2016
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:51636832394662
Cash and cash equivalents5163652115824
Short-term investments  311243838
Other undisclosed cash, cash equivalents, and short-term investments    (0)  
Receivables18161414121210
Inventory, net of allowances, customer advances and progress billings9877654
Inventory9877654
Other undisclosed current assets2222222
Total current assets:81899155586578
Noncurrent Assets
Property, plant and equipment8776654
Intangible assets, net (including goodwill)1521010101111 
Goodwill6300044 
Intangible assets, net (excluding goodwill)909101066 
Other noncurrent assets0000000
Total noncurrent assets:16117171717165
TOTAL ASSETS:24210610872768182
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities17151216141110
Accounts payable4333433
Accrued liabilities13129131087
Debt8889742
Business combination, contingent consideration, liability17      
Total current liabilities:42232025211511
Noncurrent Liabilities
Long-term debt and lease obligation40131311131618
Long-term debt, excluding current maturities40131311131618
Liabilities, other than long-term debt36001111
Other liabilities0001111
Business combination, contingent consideration, liability35      
Total noncurrent liabilities:75131312141719
Total liabilities:118363337353230
Stockholders' equity
Stockholders' equity attributable to parent124697535414952
Common stock0000000
Additional paid in capital295237234186184183181
Accumulated other comprehensive income (loss)(0)(0)(0)(0)(0)(0)0
Accumulated deficit(170)(167)(159)(151)(143)(134)(129)
Total stockholders' equity:124697535414952
TOTAL LIABILITIES AND EQUITY:24210610872768182

Income statement (P&L) ($ in millions)

9/30/2017
Q3
6/30/2017
Q2
3/31/2017
Q1
12/31/2016
Q4
9/30/2016
Q3
6/30/2016
Q2
3/31/2016
Q1
Revenues
(Revenue, Net)
23221922181917
Cost of revenue(7)(6)(5)(6)(5)(4)(4)
Gross profit:17161416131413
Operating expenses(34)(24)(22)(23)(22)(19)(19)
Operating loss:(17)(8)(8)(7)(9)(5)(6)
Nonoperating income (expense)00000(0)(1)
Investment income, nonoperating0000000
Other nonoperating income (expense)(0)(0)(0)0(0)(0)(0)
Interest and debt expense(1)(0)(1)(1)(1)(1)(1)
Loss from continuing operations before income taxes:(18)(8)(8)(7)(9)(6)(7)
Income tax expense (benefit)15(0)(0)0(0)  
Net loss:(3)(8)(8)(7)(10)(6)(7)
Other undisclosed net income attributable to parent     11
Net loss available to common stockholders, diluted:(3)(8)(8)(7)(10)(5)(7)

Comprehensive Income ($ in millions)

9/30/2017
Q3
6/30/2017
Q2
3/31/2017
Q1
12/31/2016
Q4
9/30/2016
Q3
6/30/2016
Q2
3/31/2016
Q1
Net loss:(3)(8)(8)(7)(10)(6)(7)
Comprehensive loss:(3)(8)(8)(7)(10)(6)(7)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent00(0)(0)(0)01
Comprehensive loss, net of tax, attributable to parent:(3)(8)(8)(7)(10)(5)(7)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: